Contineum Therapeutics CTNM
Last Price
52 Week Range
$3.35 - $15.25
Next Earnings Date
Mar 05 2026 (Estimate)
Next Earnings Date
Mar 05 2026 (Est.)
Last Price
CTNM Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Contineum Therapeutics, Inc. | 8-K | December 15, 2025 | |
Contineum Therapeutics, Inc. | 8-K | December 11, 2025 | |
Contineum Therapeutics, Inc. | 8-K | November 20, 2025 | |
Contineum Therapeutics, Inc. | 8-K | October 30, 2025 | |
Contineum Therapeutics, Inc. | 10-Q | October 30, 2025 | |
Contineum Therapeutics, Inc. | 8-K | September 18, 2025 | |
Contineum Therapeutics, Inc. | 8-K | August 5, 2025 | |
Contineum Therapeutics, Inc. | 10-Q | August 5, 2025 | |
Contineum Therapeutics, Inc. | 8-K | June 26, 2025 | |
Contineum Therapeutics, Inc. | 8-K | May 14, 2025 | |
Contineum Therapeutics, Inc. | 10-Q | May 14, 2025 | |
Contineum Therapeutics, Inc. | DEF 14A | April 29, 2025 | |
Contineum Therapeutics, Inc. | ARS | April 29, 2025 | |
Contineum Therapeutics, Inc. | DEFA14A | April 29, 2025 | |
Contineum Therapeutics, Inc. | 8-K | April 28, 2025 | |
Contineum Therapeutics, Inc. | 8-K | March 17, 2025 | |
Contineum Therapeutics, Inc. | 10-K | March 6, 2025 | |
Contineum Therapeutics, Inc. | 8-K | March 6, 2025 | |
Contineum Therapeutics, Inc. | 8-K | November 6, 2024 | |
Contineum Therapeutics, Inc. | 10-Q | November 6, 2024 | |
Contineum Therapeutics, Inc. | 10-Q | August 14, 2024 | |
Contineum Therapeutics, Inc. | 8-K | August 13, 2024 | |
Contineum Therapeutics, Inc. | 8-K | June 24, 2024 | |
Contineum Therapeutics, Inc. | 8-K | May 31, 2024 | |
Contineum Therapeutics, Inc. | 8-K | May 20, 2024 | |
Contineum Therapeutics, Inc. | 8-K | May 16, 2024 | |
Contineum Therapeutics, Inc. | 10-Q | May 16, 2024 | |
Contineum Therapeutics, Inc. | 8-K | April 9, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.